IMMUNOPATHOLOGY AND INFECTIOUS DISEASES Convergent Replication of Mouse Synthetic Prion Strains

[1]  Stephen J. DeArmond,et al.  Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions , 2012, Proceedings of the National Academy of Sciences.

[2]  Irina S. Alexeeva,et al.  Genesis of Mammalian Prions: From Non-infectious Amyloid Fibrils to a Transmissible Prion Disease , 2011, PLoS pathogens.

[3]  S. Mahal,et al.  Prions on the move , 2011, EMBO reports.

[4]  S. Prusiner,et al.  Conformational transformation and selection of synthetic prion strains. , 2011, Journal of molecular biology.

[5]  Fei Wang,et al.  Seeding specificity and ultrastructural characteristics of infectious recombinant prions. , 2011, Biochemistry.

[6]  Brent Race,et al.  Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays , 2010, PLoS pathogens.

[7]  S. Prusiner,et al.  Human prion strain selection in transgenic mice , 2010, Annals of neurology.

[8]  Beat Meier,et al.  Prions , 2010 .

[9]  Jacob I. Ayers,et al.  Coinfecting Prion Strains Compete for a Limiting Cellular Resource , 2010, Journal of Virology.

[10]  Charles Weissmann,et al.  Darwinian Evolution of Prions in Cell Culture , 2010, Science.

[11]  Irina S. Alexeeva,et al.  Recombinant prion protein induces a new transmissible prion disease in wild-type animals , 2010, Acta Neuropathologica.

[12]  David W. Colby,et al.  Protease-Sensitive Synthetic Prions , 2010, PLoS pathogens.

[13]  S. Prusiner,et al.  Chemical Induction of Misfolded Prion Protein Conformers in Cell Culture* , 2009, The Journal of Biological Chemistry.

[14]  David W. Colby,et al.  Design and construction of diverse mammalian prion strains , 2009, Proceedings of the National Academy of Sciences.

[15]  S. Prusiner,et al.  Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions , 2009, PLoS pathogens.

[16]  David W. Colby,et al.  Natural and synthetic prion structure from X-ray fiber diffraction , 2009, Proceedings of the National Academy of Sciences.

[17]  Brian Spencer,et al.  Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.

[18]  A. Aguzzi,et al.  Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation , 2009, Proceedings of the National Academy of Sciences.

[19]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[20]  M. Diamond,et al.  Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.

[21]  R. Kopito,et al.  Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates , 2009, Nature Cell Biology.

[22]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[23]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[24]  J. Bartz,et al.  Prion interference with multiple prion isolates , 2008, Prion.

[25]  C. Julius,et al.  Prion strain discrimination in cell culture: The cell panel assay , 2007, Proceedings of the National Academy of Sciences.

[26]  John Collinge,et al.  A General Model of Prion Strains and Their Pathogenicity , 2007, Science.

[27]  F. Cohen,et al.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes , 2006, Proceedings of the National Academy of Sciences.

[28]  D. Walsh,et al.  Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.

[29]  F. Cohen,et al.  Strain-specified characteristics of mouse synthetic prions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Cohen,et al.  Synthetic Mammalian Prions , 2004, Science.

[31]  F. Cohen,et al.  Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.

[32]  S. Prusiner,et al.  Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.

[33]  F. Cohen,et al.  Strain‐specified relative conformational stability of the scrapie prion protein , 2001, Protein science : a publication of the Protein Society.

[34]  F. Cohen,et al.  Identification of Two Prion Protein Regions That Modify Scrapie Incubation Time , 2001, Journal of Virology.

[35]  J. Aiken,et al.  Adaptation and Selection of Prion Protein Strain Conformations following Interspecies Transmission of Transmissible Mink Encephalopathy , 2000, Journal of Virology.

[36]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[37]  Clemencia Pinilla,et al.  Mapping the Prion Protein Using Recombinant Antibodies , 1998, Journal of Virology.

[38]  S. Prusiner,et al.  Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. , 1996, Genes & development.

[39]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.

[40]  F. Cohen,et al.  High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.

[41]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[43]  Stephen J. DeArmond,et al.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.

[44]  S. Prusiner,et al.  Linkage of prion protein and scrapie incubation time genes , 1986, Cell.

[45]  S. Prusiner,et al.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene , 1986, Cell.

[46]  S. Prusiner,et al.  Measurement of the scrapie agent using an incubation time interval assay , 1982, Annals of neurology.

[47]  A. Dickinson,et al.  A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. , 1969, Genetical research.

[48]  I. Pattison,et al.  The possible nature of the transmissible agent of scrapie , 1967, Veterinary Record.

[49]  E. Masliah,et al.  Correction for Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein, by , 2009 .

[50]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.